Stonebridge Financial Group LLC Purchases Shares of 462 Agilent Technologies, Inc. (NYSE:A)

Stonebridge Financial Group LLC acquired a new position in Agilent Technologies, Inc. (NYSE:A) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 462 shares of the medical research company’s stock, valued at approximately $62,000.

A number of other institutional investors have also made changes to their positions in the business. CKW Financial Group raised its stake in Agilent Technologies by 114.9% during the 4th quarter. CKW Financial Group now owns 187 shares of the medical research company’s stock valued at $25,000 after purchasing an additional 100 shares during the last quarter. Global X Japan Co. Ltd. increased its holdings in shares of Agilent Technologies by 161.1% during the 4th quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company’s stock worth $25,000 after purchasing an additional 116 shares during the period. Livelsberger Financial Advisory acquired a new position in shares of Agilent Technologies during the third quarter valued at about $28,000. Ashton Thomas Securities LLC bought a new stake in shares of Agilent Technologies in the third quarter valued at about $31,000. Finally, Fortitude Family Office LLC lifted its stake in shares of Agilent Technologies by 68.3% in the third quarter. Fortitude Family Office LLC now owns 234 shares of the medical research company’s stock valued at $35,000 after buying an additional 95 shares during the period.

Agilent Technologies Price Performance

Shares of Agilent Technologies stock opened at $136.51 on Friday. The stock has a market capitalization of $38.94 billion, a price-to-earnings ratio of 30.88, a P/E/G ratio of 4.00 and a beta of 1.07. The firm’s 50-day moving average price is $141.68 and its two-hundred day moving average price is $139.45. The company has a current ratio of 2.09, a quick ratio of 1.58 and a debt-to-equity ratio of 0.57. Agilent Technologies, Inc. has a 1-year low of $124.16 and a 1-year high of $155.35.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Monday, November 25th. The medical research company reported $1.46 EPS for the quarter, topping analysts’ consensus estimates of $1.41 by $0.05. Agilent Technologies had a return on equity of 25.43% and a net margin of 19.80%. The business had revenue of $1.70 billion for the quarter, compared to analyst estimates of $1.67 billion. During the same period in the prior year, the company earned $1.38 EPS. Agilent Technologies’s revenue for the quarter was up .8% on a year-over-year basis. On average, equities analysts predict that Agilent Technologies, Inc. will post 5.56 earnings per share for the current fiscal year.

Agilent Technologies Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, January 22nd. Investors of record on Tuesday, December 31st were given a dividend of $0.248 per share. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.24. The ex-dividend date of this dividend was Tuesday, December 31st. This represents a $0.99 annualized dividend and a yield of 0.73%. Agilent Technologies’s dividend payout ratio is 22.40%.

Insiders Place Their Bets

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,911 shares of the stock in a transaction on Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total value of $286,650.00. Following the transaction, the chief executive officer now directly owns 39,652 shares in the company, valued at approximately $5,947,800. This trade represents a 4.60 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Analyst Ratings Changes

A has been the subject of several recent research reports. Sanford C. Bernstein cut their price target on Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating for the company in a report on Tuesday, November 26th. Wells Fargo & Company cut their target price on Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating for the company in a research note on Monday, December 9th. Barclays raised Agilent Technologies from an “underweight” rating to an “equal weight” rating and raised their target price for the stock from $135.00 to $145.00 in a research report on Monday. Citigroup boosted their price target on shares of Agilent Technologies to $165.00 and gave the company a “buy” rating in a report on Thursday, December 19th. Finally, JPMorgan Chase & Co. reduced their price objective on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a report on Tuesday, November 26th. Seven equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $144.38.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.